Ken Griffin’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Buy
246,900
+15,400
+7% +$20.2K ﹤0.01% 9936
2025
Q4
$287K Buy
231,500
+51,100
+28% +$71.6K ﹤0.01% 10243
2025
Q3
$364K Sell
180,400
-76,000
-30% -$139K ﹤0.01% 9894
2025
Q2
$462K Buy
256,400
+210,100
+454% +$405K ﹤0.01% 8819
2025
Q1
$98.6K Sell
46,300
-260,700
-85% -$888K ﹤0.01% 11489
2024
Q4
$1.19M Buy
307,000
+71,700
+30% +$571K ﹤0.01% 6655
2024
Q3
$2.38M Buy
235,300
+51,700
+28% +$336K ﹤0.01% 5205
2024
Q2
$826K Sell
183,600
-45,500
-20% -$462K ﹤0.01% 6990
2024
Q1
$3.43M Buy
229,100
+16,800
+8% +$277K ﹤0.01% 4567
2023
Q4
$3.08M Buy
212,300
+161,600
+319% +$1.96M ﹤0.01% 4600
2023
Q3
$698K Buy
50,700
+14,400
+40% +$260K ﹤0.01% 7345
2023
Q2
$797K Buy
36,300
+14,500
+67% +$454K ﹤0.01% 6936
2023
Q1
$676K Buy
21,800
+12,700
+140% +$158K ﹤0.01% 7658
2022
Q4
$76.7K Buy
+9,100
New +$77.6K ﹤0.01% 11572

Other funds holding BMEA

Ken Griffin's BMEA Position: Q1 2026 in Review

Ken Griffin opened a new position in Biomea Fusion (BMEA) in Q1 2026: 656,817 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #7639 among its holdings. This is a return to the name: Ken Griffin previously reported a position in BMEA as recently as Q3 2025.

Ken Griffin first reported a position in BMEA in Q2 2021 and has held it in 16 quarters since. The position peaked at $4.02M in Q2 2022. 65 funds tracked by Wall St. Rank hold BMEA as of Q1 2026.

  • Ken Griffin held 656,817 shares of Biomea Fusion worth $1M as of Q1 2026.
  • Biomea Fusion was a new Ken Griffin position in Q1 2026.
  • Biomea Fusion made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #7639 holding.
  • Ken Griffin first reported a position in Biomea Fusion in Q2 2021 and has held it in 16 quarters since.
  • Ken Griffin's Biomea Fusion position peaked at $4.02M in Q2 2022.
  • 65 funds tracked by Wall St. Rank held Biomea Fusion as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.